Trial Profile
A real world study of Ustekinumab in patients with Psoriatic Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- 09 Mar 2018 New trial record
- 06 Mar 2018 Results published in the JCR: Journal of Clinical Rheumatology